greeksoup/ stock research
Stock research / United States / BIO / Planned sales

Bio-Rad Laboratories, Inc. planned insider sales

In the twelve months since 9 October 2025 insiders at Bio-Rad Laboratories, Inc. filed 5 Form 144 notices of planned sales, 3,487 shares worth $1.0 million at the time of filing, from 4 sellers. The latest, filed 28 May 2026: Alles Institute for Medical Research Corp (director, 10% stockholder), 700 shares worth $219,296, planned for around 28 May 2026 through Wells Fargo Clearing Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
28 May 2026Alles Institute for Medical Research CorpDirector, 10% Stockholder700$219,29628 May 2026Wells Fargo Clearing ServicesDonationForm 144
11 May 2026Eva EngelhardtOfficer550$135,59711 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
2 December 2025Michael W CrowleyOfficer776$247,9792 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
18 November 2025Alles Institute for Medical Research CorpDirector, 10% Stockholder760$228,79318 November 2025Wells Fargo Clearing ServicesDonationForm 144
6 November 2025James BarryOfficer701$214,6336 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesEmployee Stock Purchase Plan; Restricted StockForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Bio-Rad Laboratories, Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install